151 related articles for article (PubMed ID: 23201130)
1. Multicenter validation of cyclin D1, MCM7, TRIM29, and UBE2C as prognostic protein markers in non-muscle-invasive bladder cancer.
Fristrup N; Birkenkamp-Demtröder K; Reinert T; Sanchez-Carbayo M; Segersten U; Malmström PU; Palou J; Alvarez-Múgica M; Pan CC; Ulhøi BP; Borre M; Ørntoft TF; Dyrskjøt L
Am J Pathol; 2013 Feb; 182(2):339-49. PubMed ID: 23201130
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin E, maspin, Plk1, and survivin are promising prognostic protein markers for progression in non-muscle invasive bladder cancer.
Fristrup N; Ulhøi BP; Birkenkamp-Demtröder K; Mansilla F; Sanchez-Carbayo M; Segersten U; Malmström PU; Hartmann A; Palou J; Alvarez-Múgica M; Zieger K; Borre M; Ørntoft TF; Dyrskjøt L
Am J Pathol; 2012 May; 180(5):1824-34. PubMed ID: 22449953
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters.
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Requena MJ; Montironi R
Am J Clin Pathol; 2004 Sep; 122(3):444-52. PubMed ID: 15362377
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of replication protein A (RPA) expression levels in bladder urothelial carcinoma.
Levidou G; Gakiopoulou H; Kavantzas N; Saetta AA; Karlou M; Pavlopoulos P; Thymara I; Diamantopoulou K; Patsouris E; Korkolopoulou P
BJU Int; 2011 Jul; 108(2 Pt 2):E59-65. PubMed ID: 21062395
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67.
Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK
Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387
[TBL] [Abstract][Full Text] [Related]
6. Cyclin D3 expression in primary Ta/T1 bladder cancer.
Lopez-Beltran A; Requena MJ; Luque RJ; Alvarez-Kindelan J; Quintero A; Blanca AM; Rodriguez ME; Siendones E; Montironi R
J Pathol; 2006 May; 209(1):106-13. PubMed ID: 16482499
[TBL] [Abstract][Full Text] [Related]
7. MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma.
Qu K; Wang Z; Fan H; Li J; Liu J; Li P; Liang Z; An H; Jiang Y; Lin Q; Dong X; Liu P; Liu C
Cell Death Dis; 2017 Feb; 8(2):e2603. PubMed ID: 28182015
[TBL] [Abstract][Full Text] [Related]
8. Expression of cell cycle proteins in T1a and T1b urothelial bladder carcinoma and their value in predicting tumor progression.
Mhawech P; Greloz V; Oppikofer C; Szalay-Quinodoz I; Herrmann F
Cancer; 2004 Jun; 100(11):2367-75. PubMed ID: 15160340
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of Ki-67, Cyclin D1, p16INK4a, and Survivin as a predictive tool for recurrence and progression-free survival in papillary urothelial bladder cancer pTa / pT1 G2 (WHO 1973).
March-Villalba JA; Ramos-Soler D; Soriano-Sarrió P; Hervás-Marín D; Martínez-García L; Martínez-Jabaloyas JM
Urol Oncol; 2019 Feb; 37(2):158-165. PubMed ID: 30446453
[TBL] [Abstract][Full Text] [Related]
10. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
[TBL] [Abstract][Full Text] [Related]
11. EZH2, Ki-67 and MCM7 are prognostic markers in prostatectomy treated patients.
Laitinen S; Martikainen PM; Tolonen T; Isola J; Tammela TL; Visakorpi T
Int J Cancer; 2008 Feb; 122(3):595-602. PubMed ID: 17943722
[TBL] [Abstract][Full Text] [Related]
12. Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information.
Tobin NP; Lundgren KL; Conway C; Anagnostaki L; Costello S; Landberg G
Hum Pathol; 2012 Nov; 43(11):2053-61. PubMed ID: 22647349
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in stage T1 grade 3 bladder cancer survival: the role of G1-S modulators (p53, p21Waf1, p27kip1, Cyclin D1, and Cyclin D3) and proliferation index (ki67-MIB1).
Lopez-Beltran A; Luque RJ; Alvarez-Kindelan J; Quintero A; Merlo F; Carrasco JC; Requena MJ; Montironi R
Eur Urol; 2004 May; 45(5):606-12. PubMed ID: 15082203
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance in substaging ofT1 urinary bladder urothelial carcinoma on transurethral resection.
Chang WC; Chang YH; Pan CC
Am J Surg Pathol; 2012 Mar; 36(3):454-61. PubMed ID: 22261706
[TBL] [Abstract][Full Text] [Related]
15. UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy.
Morikawa T; Kawai T; Abe H; Kume H; Homma Y; Fukayama M
Int J Clin Exp Pathol; 2013; 6(7):1367-74. PubMed ID: 23826418
[TBL] [Abstract][Full Text] [Related]
16. Impact of Cyclin D1 and Heterogeneous Nuclear Ribonucleoprotein-K (HnRNP-K) on Urinary Bladder Carcinogenesis.
Aboushousha T; Hammam O; Helal N; El Dahshan S
Asian Pac J Cancer Prev; 2018 Feb; 19(2):513-519. PubMed ID: 29480994
[TBL] [Abstract][Full Text] [Related]
17. The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
Oddens JR; Sylvester RJ; Brausi MA; Kirkels WJ; van de Beek C; van Andel G; de Reijke TM; Prescott S; Witjes JA; Oosterlinck W
Eur Urol; 2014 Oct; 66(4):694-701. PubMed ID: 24948466
[TBL] [Abstract][Full Text] [Related]
18. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
[TBL] [Abstract][Full Text] [Related]
19. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder.
Yurakh AO; Ramos D; Calabuig-Fariñas S; López-Guerrero JA; Rubio J; Solsona E; Romanenko AM; Vozianov AF; Pellin A; Llombart-Bosch A
Eur Urol; 2006 Sep; 50(3):506-15; discussion 515. PubMed ID: 16624482
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
Kandimalla R; van Tilborg AA; Kompier LC; Stumpel DJ; Stam RW; Bangma CH; Zwarthoff EC
Eur Urol; 2012 Jun; 61(6):1245-56. PubMed ID: 22284968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
